1. |
Rajkumar SV, Dimopoulos MA, Palumbo A,et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol, 2014, 15(12): E538-E548.
|
2. |
张明慧, 孙薏, 张俊琪, 等. 硼替佐米联合地塞米松和沙利度胺治疗老年多发性骨髓瘤疗效观察. 华西医学, 2014, 29(4): 603-606.
|
3. |
Biran N, Ely S, Chari A,et al. Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniques. Curr Hematol Malig Rep. 2014, 9(4): 368-378.
|
4. |
中国医师协会血液科医师分会, 中华医学会血液学分会, 中国多发性骨髓瘤工作组. 中国多发性骨髓瘤诊治指南(2013年修订). 中华内科杂志, 2013, 52(9): 791-795.
|
5. |
Carulli G, Ottaviano V, Cannizzo E,et al. Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Ter, 2012, 163(5): 387-392.
|
6. |
Bataille R, Jégo G, Robillard N,et al. The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy. Haematologica, 2010, 91(9): 1234-1240.
|
7. |
Paíno T, Sarasquete ME, Paiva B,et al. Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines. PLoS One, 2014, 9(3): e92378.
|
8. |
Caraux A, Klein B, Paiva B,et al. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Haematologica, 2010, 95(6): 1016-1020.
|
9. |
Chillemi A, Zaccarello G, Quarona V,et al. CD38 and bone marrow microenvironment. Front Biosci (Landmark Ed), 2014, 19: 152-162.
|
10. |
Paiva B, Almeida J, Pérez-Andrés M,et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorder. Cytometry B Clin Cytom. 2010, 78(4): 239-252.
|
11. |
Berdeja JG. Lorvotuzumab mertansine: antibody-drug-conjugate for CD56+ multiple myeloma. Front Biosci (Landmark Ed). 2014, 1(19): 163-170.
|
12. |
Naseem S, Kaur S, Gupta R,et al. Plasma cell leukemia: case series from a tertiary center with review of literature. Indian J Hematol Blood Transfus, 2012, 28(1): 10-14.
|
13. |
Kumar S, Kimlinger T, Morice W. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol, 2010, 23(3): 433-451.
|
14. |
Chastain EC, Duncavage EJ. Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma. Arch Pathol Lab Med, 2015, 139(5): 602-607.
|
15. |
刘艳荣. 实用流式细胞术. 北京: 北京大学医学出版社, 2010: 348.
|
16. |
Manasanch EE, Salem DA, Yuan CM,et al. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method. Leuk Lymphoma, 2015, 56(5): 1416-1424.
|